Pfizer ends study on potential lung cancer drug Product Design & Development By AP Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack ...
Pfizer says Sutent fails in breast cancer studies Las Vegas Sun Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies News 10NBC Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies Seattle Post Intelligencer Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies WBOC TV 16 Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer ends study on potential lung cancer drug Washington Post AP NEW YORK -- Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, ...
Pfizer Says Two Cancer Drugs Fail in Clinical Trials Bloomberg Pfizer also stopped a trial of figitumumab in combination with another medicine for advanced lung cancer patients who already had been treated with other ...
Pfizer ends study on potential lung cancer drug Salon By AP Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack ...
Pfizer says Sutent fails in breast cancer studies The Associated Press Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Merlin Olsen Dies of Cancer: What is Mesothelioma? Gather.com ... which prevents more fluid from accumulating and pressing on the lung. Despite treatment with chemotherapy, radiation therapy or sometimes surgery, ...
Pfizer ends study on potential lung cancer drug The Associated Press NEW YORK Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, ...
Pfizer ends study on potential lung cancer drug KAALtv.com (AP) NEW YORK - Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, ...
Pfizer says Sutent fails in breast cancer studies Pharmaceutical Processing Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
